{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute therapy to accelerate visual recovery in optic neuritis Significant visual deficit (6/18) warrants aggressive management\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection prophylaxis while on high-dose corticosteroids\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Diagnosis (MS vs NMO vs Sarcoidosis) must be confirmed via MRI and serology before selecting long-term immunotherapy\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute therapy to accelerate visual recovery in optic neuritis\", \"Significant visual deficit (6/18) warrants aggressive management\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection prophylaxis while on high-dose corticosteroids\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Diagnosis (MS vs NMO vs Sarcoidosis) must be confirmed via MRI and serology before selecting long-term immunotherapy\"]}]"
}